Patents by Inventor Jinyi Cheng

Jinyi Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIRUS-LIKE PARTICLE VACCINES
    Publication number: 20160185826
    Abstract: The invention is directed to dimeric fusion proteins and virus-like particles comprising such dimeric fusion proteins. These dimeric fusion proteins comprise an antigen or antigenic fragment carried between two viral structural proteins or fragments thereof, with or without linkers, in a manner that, relative to traditional monomeric platforms, minimizes steric hindrance among the antigen or antigenic fragment and the viral structural proteins or fragments thereof. This novel design provides for multivalent vaccines and enhanced immunogenicity. The invention also relates to nucleic acids encoding such dimeric fusion proteins and host cells comprising such nucleic acids. The invention further relates to pharmaceutical compositions comprising the dimeric fusion proteins and/or virus-like particles of the invention, and methods of prevention or treatment using such compositions.
    Type: Application
    Filed: February 4, 2016
    Publication date: June 30, 2016
    Applicant: Medigen Biotechnology Corp.
    Inventors: Young-Sun LIN, Jinyi CHENG, Ya-Lin CHIANG, Ming-Cheng CHEN, Kuei-Tai A. LAI, Chih Ya YANG
  • Virus-like Particle Vaccines
    Publication number: 20160038586
    Abstract: The invention is directed to dimeric fusion proteins and virus-like particles comprising such dimeric fusion proteins. These dimeric fusion proteins comprise an antigen or antigenic fragment carried between two viral structural proteins or fragments thereof, with or without linkers, in a manner that, relative to traditional monomeric platforms, minimizes steric hindrance among the antigen or antigenic fragment and the viral structural proteins or fragments thereof. This novel design provides for multivalent vaccines and enhanced immunogenicity. The invention also relates to nucleic acids encoding such dimeric fusion proteins and host cells comprising such nucleic acids. The invention further relates to pharmaceutical compositions comprising the dimeric fusion proteins and/or virus-like particles of the invention, and methods of prevention or treatment using such compositions.
    Type: Application
    Filed: August 6, 2015
    Publication date: February 11, 2016
    Applicant: MEDIGEN BIOTECHNOLOGY CORP.
    Inventors: Young-Sun Lin, Jinyi Cheng, Ya-Lin Chiang, Ming-Cheng Chen, Kuei-Tai A. Lai, Chih Ya Yang